Simplex Trading’s ESSA Pharma EPIX Stock Holding History

Simplex Trading’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,300	Closed	-$3K	–	8926
2025 Q3	$3K	Buy	+20,300	New	+$24.3K	﹤0.01%	8496
2024 Q2	–	Sell	-3,200	Closed	-$27K	–	9033
2024 Q1	$27K	Buy	3,200 +2,200	+220%	+$19.2K	﹤0.01%	6835
2023 Q4	$6K	Sell	1,000 -6,000	-86%	-$29.6K	﹤0.01%	7739
2023 Q3	$21K	Sell	7,000 -4,300	-38%	-$12.4K	﹤0.01%	6569
2023 Q2	$30K	Sell	11,300 -14,600	-56%	-$42.8K	﹤0.01%	6346
2023 Q1	$76K	Buy	+25,900	New	+$76.1K	﹤0.01%	5464
2022 Q2	–	Sell	-400	Closed	-$2K	–	10211
2022 Q1	$2K	Sell	400 -300	-43%	-$2.64K	﹤0.01%	9839
2021 Q4	$9K	Buy	+700	New	+$7.8K	﹤0.01%	9109

Simplex Trading's EPIX Position: Q4 2025 in Review

Simplex Trading sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 20,381 shares — an estimated $3K sold.

Simplex Trading first reported a position in EPIX in Q3 2022 and held it in 8 quarters. The position peaked at $36K in Q1 2024. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

Simplex Trading reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 20,381 ESSA Pharma shares in Q4 2025, an estimated $3K.
Simplex Trading first reported a position in ESSA Pharma in Q3 2022 and held it in 8 quarters.
Simplex Trading's ESSA Pharma position peaked at $36K in Q1 2024.
0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.